Epidemiology of Head and Neck Cancer

Surgical Oncology Clinics of North America

Volumn 24, Issue 3, 2015, Pages 379-396

  Rettig, Eleni M ^a   D'Souza, Gypsyamber ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alcohol; Epidemiology; Head and neck cancer; Human papillomavirus; Tobacco

Indexed keywords

ALCOHOL;

AGE; ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; DEMOGRAPHY; DISEASE ASSOCIATION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; OUTCOME ASSESSMENT; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; SEX DIFFERENCE; SEXUAL BEHAVIOR; SMOKING; SOCIAL STATUS; SURVIVAL RATE; TOBACCO; TREND STUDY; UNITED STATES; VIRUS IDENTIFICATION; WART VIRUS; COMPLICATION; FEMALE; HEAD AND NECK NEOPLASMS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PREVALENCE; PROGNOSIS; VIROLOGY;

FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 84929504129     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2015.03.001     Document Type: Review

References (133)

1. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917.
2. Howlander N., Noone A.M., Krapcho M., et al. SEER cancer statistics review (CSR) 1975-2011 2014, National Cancer Institute, Bethesda (MD).
3. Licitra L., Locati L.D., Bossi P., et al. Head and neck tumors other than squamous cell carcinoma. Curr Opin Oncol 2004, 16(3):236-241.
4. Gillison M.L., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008, 100(6):407-420.
5. Agrawal N., Frederick M.J., Pickering C.R., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333(6046):1154-1157.
6. Stransky N., Egloff A.M., Tward A.D., et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333(6046):1157-1160.
7. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007, 356:1944-1956.
8. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100(4):261-269.
9. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363(1):24-35.
10. Chaturvedi A.K., Engels E.A., Anderson W.F., et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4):612-619.
11. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29(32):4294-4301.
12. Simard E.P., Torre L.A., Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 2014, 50(5):387-403.
13. Blot W.J., McLaughlin J.K., Winn D.M., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48(11):3282-3287.
14. Hashibe M., Brennan P., Benhamou S., et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007, 99(10):777-789.
15. Vineis P., Alavanja M., Buffler P., et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004, 96(2):99-106.
16. Franceschi S., Talamini R., Barra S., et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990, 50(20):6502-6507.
17. Schlecht N.F., Franco E.L., Pintos J., et al. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 1999, 10(4):412-418.
18. Secretan B., Straif K., Baan R., et al. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009, 10(11):1033-1034.
19. Boffetta P., Hecht S., Gray N., et al. Smokeless tobacco and cancer. Lancet Oncol 2008, 9(7):667-675.
20. Zhou J., Michaud D.S., Langevin S.M., et al. Smokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England. Int J Cancer 2013, 132:1911-1917.
21. Anantharaman D., Marron M., Lagiou P., et al. Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011, 47(8):725-731.
22. Hashibe M., Boffetta P., Zaridze D., et al. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 2007, 165(7):814-820.
23. Brugere J., Guenel P., Leclerc A., et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986, 57(2):391-395.
24. Menvielle G., Luce D., Goldberg P., et al. Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case-control study in France. Eur J Cancer Prev 2004, 13(3):165-172.
25. Hashibe M., Brennan P., Chuang S.C., et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009, 18(2):541-550.
26. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2011. 2014; based on November 2013 SEER data submission, posted to the SEER web site, April 2014. Available at:. Accessed October 15, 2014. http://seer.cancer.gov/csr/1975_2011/.
27. Thun M., Peto R., Boreham J., et al. Stages of the cigarette epidemic on entering its second century. Tob Control 2012, 21(2):96-101.
28. Settle K., Posner M.R., Schumaker L.M., et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Canc Prev Res 2009, 2(9):776-781.
29. Boing A.F., Antunes J.L., de Carvalho M.B., et al. How much do smoking and alcohol consumption explain socioeconomic inequalities in head and neck cancer risk?. J Epidemiol Community Health 2011, 65(8):709-714.
30. Menvielle G., Luce D., Goldberg P., et al. Smoking, alcohol drinking, occupational exposures and social inequalities in hypopharyngeal and laryngeal cancer. Int J Epidemiol 2004, 33(4):799-806.
31. Hwang E., Johnson-Obaseki S., McDonald J.T., et al. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007. Oral Oncol 2013, 49(11):1072-1076.
32. Conway D.I., Brenner D.R., McMahon A.D., et al. Estimating and explaining the effect of education and income on head and neck cancer risk: INHANCE consortium pooled analysis of 31 case-control studies from 27 countries. Int J Cancer 2014, 36:1125-1139.
33. Cavelaars A.E., Kunst A.E., Geurts J.J., et al. Educational differences in smoking: international comparison. BMJ 2000, 320(7242):1102-1107.
34. Agaku I., King B., Dube S.R., Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, CDC Current cigarette smoking among adults - United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61(44):889-894.
35. Grulich A.E., van Leeuwen M.T., Falster M.O., et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007, 370(9581):59-67.
36. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Canc 2003, 89(7):1221-1227.
37. Jensen P., Hansen S., Moller B., et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999, 40(2 Pt 1):177-186.
38. Piselli P., Serraino D., Segoloni G.P., et al. Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Canc 2013, 49(2):336-344.
39. Long J.L., Engels E.A., Moore R.D., et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS 2008, 22(4):489-496.
40. Begum S., Cao D., Gillison M., et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11(16):5694-5699.
41. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000, 92(9):709-720.
42. Lin B.M., Wang H., D'Souza G., et al. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer 2013, 119:3462-3471.
43. Weinberger P.M., Yu Z., Haffty B.G., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006, 24(5):736-747.
44. Lewis J.S., Thorstad W.L., Chernock R.D., et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010, 34(8):1088-1096.
45. Mehanna H., Beech T., Nicholson T., et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012, 35:747-755.
46. Park K., Cho K.J., Lee M., et al. p16 immunohistochemistry alone is a better prognosticator in tonsil cancer than human papillomavirus in situ hybridization with or without p16 immunohistochemistry. Acta Otolaryngol 2013, 133(3):297-304.
47. Lingen M.W., Xiao W., Schmitt A., et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013, 49(1):1-8.
48. Tota J.E., Chevarie-Davis M., Richardson L.A., et al. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med 2011, 53(Suppl 1):S12-S21.
49. Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95(23):1772-1783.
50. Gillison M.L., Alemany L., Snijders P.J., et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012, 30(Suppl 5):F34-F54.
51. Gillison M.L., Broutian T., Pickard R.K., et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012, 307(7):693-703.
52. Mork J., Lie A.K., Glattre E., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344(15):1125-1131.
53. Kreimer A.R., Johansson M., Waterboer T., et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013, 31(21):2708-2715.
54. Schwartz S.M., Daling J.R., Doody D.R., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998, 90(21):1626-1636.
55. Bajos N., Bozon M., Beltzer N., et al. Changes in sexual behaviours: from secular trends to public health policies. AIDS 2010, 24(8):1185-1191.
56. D'Souza G., Cullen K., Bowie J., et al. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 2014, 9:e86023.
57. Turner C.F., Danella R.D., Rogers S.M. Sexual behavior in the United States 1930-1990: trends and methodological problems. Sex Transm Dis 1995, 22(3):173-190.
58. Schmidt G., Sigusch V. Changes in sexual behavior among young males and females between 1960-1970. Arch Sex Behav 1972, 2(1):27-45.
59. Pickard R.K., Xiao W., Broutian T.R., et al. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012, 39(7):559-566.
60. Beachler D.C., Weber K.M., Margolick J.B., et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2012, 21(1):122-133.
61. Read T.R., Hocking J.S., Vodstrcil L.A., et al. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One 2012, 7:e49324.
62. D'Souza G., Agrawal Y., Halpern J., et al. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009, 199(9):1263-1269.
63. Lang Kuhs K.A., Gonzalez P., Struijk L., et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J Infect Dis 2013, 208(10):1643-1652.
64. Kreimer A.R., Alberg A.J., Daniel R., et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 2004, 189(4):686-698.
65. Videla S., Darwich L., Canadas M.P., et al. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men. Sex Transm Dis 2013, 40(1):3-10.
66. Hafkamp H.C., Manni J.J., Haesevoets A., et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008, 122(12):2656-2664.
67. D'Souza G., Gross N.D., Pai S.I., et al. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol 2014, 32:2408-2415.
68. Fakhry C., Gillison M.L., D'Souza G. Tobacco use and oral HPV-16 infection. JAMA 2014, 312(14):1465-1467.
69. Rischin D., Young R.J., Fisher R., et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 2010, 28(27):4142-4148.
70. Schwartz S.R., Yueh B., McDougall J.K., et al. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 2001, 125(1):1-9.
71. Sethi S., Ali-Fehmi R., Franceschi S., et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer 2012, 131(5):1179-1186.
72. Mellin H., Friesland S., Lewensohn R., et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000, 89(3):300-304.
73. De Petrini M., Ritta M., Schena M., et al. Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol 2006, 29(1):25-33.
74. Kumar B., Cordell K.G., Lee J.S., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008, 26(19):3128-3137.
75. Worden F.P., Kumar B., Lee J.S., et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008, 26(19):3138-3146.
76. Heath S., Willis V., Allan K., et al. Clinically significant human papilloma virus in squamous cell carcinoma of the head and neck in UK practice. Clin Oncol 2012, 24(1):e18-e23.
77. Gayar O.H., Ruterbusch J.J., Elshaikh M., et al. Oropharyngeal carcinoma in young adults: an alarming national trend. Otolaryngol Head Neck Surg 2014, 150(4):594-601.
78. D'Souza G., Kluz N., Wentz A., et al. Oral human papillomavirus (HPV) infection among unvaccinated high-risk young adults. Cancers 2014, 6(3):1691-1704.
79. Leichliter J.S., Chandra A., Liddon N., et al. Prevalence and correlates of heterosexual anal and oral sex in adolescents and adults in the United States. J Infect Dis 2007, 196:1852-1859.
80. Sturgis E.M., Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 2007, 110(7):1429-1435.
81. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General 2014, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA).
82. Jemal A., Simard E.P., Dorell C., et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013, 105(3):175-201.
83. Forte T., Niu J., Lockwood G.A., et al. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009. Cancer Causes Control 2012, 23(8):1343-1348.
84. Mayor S. Tobacco atlas illustrates shift to low income countries. BMJ 2009, 338:b981.
85. Eriksen M.P., Mackay J., Ross H., et al. The tobacco atlas. 4th ed. Completely revised and updated. ed 2012, American Cancer Society, Atlanta (GA).
86. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 2005, 24(1):9-17.
87. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009, 45(4-5):309-316.
88. Samet J.M. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin 2013, 23(2):103-112.
89. Chaturvedi A.K., Anderson W.F., Lortet-Tieulent J., et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013, 31(36):4550-4559.
90. McCormack V.A., Boffetta P. Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol 2011, 22(11):2349-2357.
91. Danaei G., Vander Hoorn S., Lopez A.D., et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366(9499):1784-1793.
92. Conway D.I., Stockton D.L., Warnakulasuriya K.A., et al. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999)-recent trends and regional variation. Oral Oncol 2006, 42(6):586-592.
93. Patel S.C., Carpenter W.R., Tyree S., et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011, 29(11):1488-1494.
94. Koch W.M., Lango M., Sewell D., et al. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999, 109(10):1544-1551.
95. Li R., Faden D.L., Fakhry C., et al. Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck 2014, [Epub ahead of print].
96. Hammarstedt L., Lindquist D., Dahlstrand H., et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006, 119(11):2620-2623.
97. Edge S.B., American Joint Committee on Cancer AJCC cancer staging manual 2010, Springer, New York. 7th edition.
98. Pfister D.G., Ang K., Brockstein B., et al. NCCN practice guidelines for head and neck cancers. Oncology 2000, 14(11A):163-194.
99. Pulte D., Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 2010, 15(9):994-1001.
100. Straetmans J.M., Olthof N., Mooren J.J., et al. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009, 119(10):1951-1957.
101. Fischer C.A., Kampmann M., Zlobec I., et al. p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010, 21(10):1961-1966.
102. O'Rorke M.A., Ellison M.V., Murray L.J., et al. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012, 48(12):1191-1201.
103. Posner M.R., Lorch J.H., Goloubeva O., et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol 2011, 22(5):1071-1077.
104. Masterson L., Moualed D., Liu Z.W., et al. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. Eur J Canc 2014, 50(15):2636-2648.
105. Isayeva T., Li Y., Maswahu D., et al. Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 2012, 6(Suppl 1):S104-S120.
106. Johnson J.T., Myers E.N., Bedetti C.D., et al. Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985, 111(8):534-537.
107. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27(10):843-850.
108. Soo K.C., Carter R.L., O'Brien C.J., et al. Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 1986, 96(10):1145-1148.
109. Ravasz L.A., Slootweg P.J., Hordijk G.J., et al. The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg 1991, 19(7):314-318.
110. Spiro R.H., Guillamondegui O., Paulino A.F., et al. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 1999, 21(5):408-413.
111. Skinner H.D., Sandulache V.C., Ow T.J., et al. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. Clin Cancer Res 2012, 18(1):290-300.
112. Koch W.M., Brennan J.A., Zahurak M., et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996, 88(21):1580-1586.
113. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002, 62(24):7350-7356.
114. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368(9538):843-854.
115. Pignon J.P., le Maitre A., Maillard E., et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009, 92(1):4-14.
116. Paleri V., Wight R.G., Silver C.E., et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol 2010, 46(10):712-719.
117. Gillison M.L., Zhang Q., Jordan R., et al. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012, 30:2102-2111.
118. Browman G.P., Mohide E.A., Willan A., et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck 2002, 24(12):1031-1037.
119. Browman G.P., Wong G., Hodson I., et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993, 328(3):159-163.
120. Chen A.M., Chen L.M., Vaughan A., et al. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy. Am J Clin Oncol 2011, 34(3):270-275.
121. Do K.A., Johnson M.M., Doherty D.A., et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003, 14(2):131-138.
122. Schrank T.P., Han Y., Weiss H., et al. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States-possible role for human papillomavirus in survival disparities. Head Neck 2011, 33(1):45-53.
123. Molina M.A., Cheung M.C., Perez E.A., et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer 2008, 113(10):2797-2806.
124. Isayeva T., Xu J., Dai Q., et al. African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis. Hum Pathol 2014, 45(2):310-319.
125. Ha P.K., Califano J.A. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 2003, 14(5):363-369.
126. Argiris A., Karamouzis M.V., Raben D., et al. Head and neck cancer. Lancet 2008, 371(9625):1695-1709.
127. Hordijk G.J., de Jong J.M. Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol 1983, 97(7):619-621.
128. Erkal H.S., Mendenhall W.M., Amdur R.J., et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 2001, 19(5):1358-1362.
129. Schwartz L.H., Ozsahin M., Zhang G.N., et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994, 74:1933-1938.
130. Chuang S.C., Scelo G., Tonita J.M., et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer 2008, 123(10):2390-2396.
131. Day G.L., Blot W.J., Shore R.E., et al. Second cancers following oral and pharyngeal cancer: patients' characteristics and survival patterns. Eur J Canc B Oral Oncol 1994, 30B(6):381-386.
132. Koch W.M. Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up. Otolaryngol Clin North Am 2012, 45(4):779-793.
133. Fakhry C., Zhang Q., Nguyen-Tan P.F., et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 2014, 32(30):3365-3373.